SCHEMBL19906264

SCHEMBL19906264

Cc1cc2nc(-c3ccnc(-c4cccc5c4OCC(=O)N5C)c3)sc2c(-c2ccc(Cl)cc2)c1CC(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER3 P43115 1/20 0.34
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KMT2A Q03164 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
FABP4 P15090 1/20 0.33
PDE5A O76074 1/20 0.32
PDE1A P54750 1/20 0.32
PDE1B Q01064 1/20 0.32
PDE4D Q08499 1/20 0.32
PDE7A Q13946 1/20 0.32
PDE1C Q14123 1/20 0.32
PDE3A Q14432 1/20 0.32
HTR1A P08908 4/20 0.31
HTR1D P28221 4/20 0.31
HTR1B P28222 4/20 0.31
SLC6A4 P31645 4/20 0.31
KCNH2 Q12809 4/20 0.31
TRPA1 O75762 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19906263 0.90 EIF4EBP1 (0.32) PTGER3KDM4ELMNASMN1; SMN2
SCHEMBL19905918 0.88 PTGDR2 (0.34) KDM4EMEN1ALDH1A1KMT2APTGDR2
SCHEMBL19906191 0.87 GYS1 (0.35) KDM4EMEN1ALDH1A1KMT2APTGDR2
SCHEMBL19906202 0.87 PTGER3 (0.40) PTGER3KDM4EMEN1ALDH1A1KMT2A
SCHEMBL15342600 0.84 CYP3A4 (0.34)
SCHEMBL15342196 0.83 PTGER3 (0.30) PTGER3
SCHEMBL19906127 0.83 FABP4 (0.36) KDM4EMEN1ALDH1A1KMT2APTGDR2
SCHEMBL19906003 0.82 TRIM24 (0.41) KDM4EMEN1ALDH1A1KMT2APTGDR2
SCHEMBL19905862 0.80 KDM4E (0.37) KDM4EMEN1ALDH1A1KMT2APTGDR2
SCHEMBL19906196 0.79 PTGER3 (0.34) PTGER3KDM4EMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3070081-B1 BENZOTHIAZOL-6-YL ACETIC ACID DERIVATIVES AND THEIR USE FOR TREATING AN HIV INFECTION GILEAD SCIENCES INC (US) 2018-02-28 EP disclosed